N/A
N=191
Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis
Schizophrenia · First Episode Psychosis
Bottom Line
View on ClinicalTrials.gov: NCT03975400 ↗Enrolled (actual)
191
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Reducing the Duration of Untreated Psychosis — 5.32; 5.38 Days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- search engine advertisement campaign (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Northwell Health
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Reducing the Duration of Untreated Psychosis |
5.32; 5.38 | — |
| SECONDARY Rates of Referrals |
86.29; 32.10 | — |
Summary
There is compelling evidence that longer duration of untreated psychosis independently predicts negative outcomes. The proposal aims to explore whether targeted and proactive online outreach through search engine advertisements, coupled with engaging, informative, and interactive online resources, can effectively reduce the duration of untreated psychosis and facilitate earlier treatment initiation in New York State. Results from this initiative will be critical to informing the subsequent design and conduct of larger, focused, and proactive digital media campaigns targeting patient with First Episode Psychosis and their caregivers online, intended to accelerate linkage to care and reduce the duration of untreated psychosis throughout the U.S.
Eligibility Criteria
Inclusion Criteria: All individuals searching online for information related to mental health
Exclusion Criteria: none
Data sourced from ClinicalTrials.gov (NCT03975400). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.